Literature DB >> 26980569

New Insight into 2-Methoxyestradiol- a Possible Physiological Link between Neurodegeneration and Cancer Cell Death.

Magdalena Gorska1, Alicja Kuban-Jankowska, Jaroslaw Slawek, Michal Wozniak.   

Abstract

The pathways leading to development of neurodegenerative disease and cancer cell death may overlap. Interestingly, the main neurodegeneration-causing factors have been suggested to play a pivotal role in the regulation of tumor growth. Another common component in neurodegenerations and cancer is nitro-oxidative stress. Depending on the environmental conditions, the nitro-oxidative stress may lead to cancerogenesis or cancer cell death. On the other side, it may also result in a variety of neurodegenerative diseases. Based on the literature data, we suggest that 2-methoxyestradiol may be considered as a physiological link between development of neurodegenerations and cancer cell death. 2-methoxyestradiol is a physiological compound, a metabolite of 17β-estradiol. Interestingly, 2-methoxyestradiol, branded as Panzem, is also considered as a potent anticancer agent, currently investigated in several clinical trials. The review aims on making closer the facts concerning anticancer and plausible neurotoxic activities of 2-methoxyestradiol, which may suggest adverse neurological long-term effects of the drug in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26980569     DOI: 10.2174/0929867323666160316123443

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  6 in total

1.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Stephan A Eisler; Ugo Perricone; Giosuè Lo Bosco; Giampaolo Barone; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

2.  Synthesis of Artemisinin-Estrogen Hybrids Highly Active against HCMV, P. falciparum, and Cervical and Breast Cancer.

Authors:  Tony Fröhlich; Anita Kiss; János Wölfling; Erzsébet Mernyák; Ágnes E Kulmány; Renáta Minorics; István Zupkó; Maria Leidenberger; Oliver Friedrich; Barbara Kappes; Friedrich Hahn; Manfred Marschall; Gyula Schneider; Svetlana B Tsogoeva
Journal:  ACS Med Chem Lett       Date:  2018-10-19       Impact factor: 4.345

Review 3.  2-Methoxyestradiol Reverses the Pro-Carcinogenic Effect of L-Lactate in Osteosarcoma 143B Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Agnieszka Daca; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

4.  Modification of DNA structure by reactive nitrogen species as a result of 2-methoxyestradiol-induced neuronal nitric oxide synthase uncoupling in metastatic osteosarcoma cells.

Authors:  Magdalena Gorska-Ponikowska; Agata Ploska; Dagmara Jacewicz; Michal Szkatula; Giampaolo Barone; Giosuè Lo Bosco; Fabrizio Lo Celso; Aleksandra M Dabrowska; Alicja Kuban-Jankowska; Monika Gorzynik-Debicka; Narcyz Knap; Lech Chmurzynski; Lawrence Wawrzyniec Dobrucki; Leszek Kalinowski; Michal Wozniak
Journal:  Redox Biol       Date:  2020-03-28       Impact factor: 11.799

Review 5.  Regulation of Mitochondrial Dynamics in Parkinson's Disease-Is 2-Methoxyestradiol a Missing Piece?

Authors:  Paulina Bastian; Jaroslaw Dulski; Anna Roszmann; Dagmara Jacewicz; Alicja Kuban-Jankowska; Jaroslaw Slawek; Michal Wozniak; Magdalena Gorska-Ponikowska
Journal:  Antioxidants (Basel)       Date:  2021-02-06

6.  2-Methoxyestradiol and Its Combination with a Natural Compound, Ferulic Acid, Induces Melanoma Cell Death via Downregulation of Hsp60 and Hsp90.

Authors:  Anna Kamm; Paulina Przychodzeń; Alicja Kuban-Jankowska; Antonella Marino Gammazza; Francesco Cappello; Agnieszka Daca; Michał A Żmijewski; Michał Woźniak; Magdalena Górska-Ponikowska
Journal:  J Oncol       Date:  2019-10-02       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.